These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34066894)

  • 21. Binding and activity of sulfated metabolites of lower-chlorinated polychlorinated biphenyls towards thyroid hormone receptor alpha.
    Ren XM; Li CH; Zhang JQ; Guo LH
    Ecotoxicol Environ Saf; 2019 Sep; 180():686-692. PubMed ID: 31146155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-related receptor γ is a novel target for Lower-Chlorinated Polychlorinated Biphenyls and their hydroxylated and sulfated metabolites.
    Cao LY; Ren XM; Guo LH
    Environ Pollut; 2019 Nov; 254(Pt B):113088. PubMed ID: 31491697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the structure determinants of pyrazinone derivatives as PDE5 3HC8 inhibitors: an in silico analysis.
    Li Y; Wu W; Ren H; Wang J; Zhang S; Li G; Yang L
    J Mol Graph Model; 2012 Sep; 38():112-22. PubMed ID: 23085160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of hydroxylated and quinoid PCB metabolites: inhibition of gap junctional intercellular communication and activation of aryl hydrocarbon and estrogen receptors in hepatic and mammary cells.
    Machala M; Bláha L; Lehmler HJ; Plísková M; Májková Z; Kapplová P; Sovadinová I; Vondrácek J; Malmberg T; Robertson LW
    Chem Res Toxicol; 2004 Mar; 17(3):340-7. PubMed ID: 15025504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-dioxin-like PCBs inhibit [(3)H]WIN-35,428 binding to the dopamine transporter: a structure-activity relationship study.
    Wigestrand MB; Stenberg M; Walaas SI; Fonnum F; Andersson PL
    Neurotoxicology; 2013 Dec; 39():18-24. PubMed ID: 23933243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling study of CP-690550 derivatives as JAK3 kinase inhibitors through combined 3D-QSAR, molecular docking, and dynamics simulation techniques.
    Wang JL; Cheng LP; Wang TC; Deng W; Wu FH
    J Mol Graph Model; 2017 Mar; 72():178-186. PubMed ID: 28107751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of Predictive Quantitative Structure-Activity Relationship Models for Estrogenic Activities of Hydroxylated Polychlorinated Biphenyls.
    Akinola LK; Uzairu A; Shallangwa GA; Abechi SE
    Environ Toxicol Chem; 2023 Apr; 42(4):823-834. PubMed ID: 36692119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure-activity relationship for estrogenic flavonoids from Psoralea corylifolia.
    Zhang T; Zhong S; Meng Y; Deng W; Hou L; Wang Y; Xing X; Guan T; Zhang J; Li T
    J Pharm Biomed Anal; 2018 Nov; 161():129-135. PubMed ID: 30149188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicology and carcinogenesis studies of 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Nov; (559):1-174. PubMed ID: 21383778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico study on β-aminoketone derivatives as thyroid hormone receptor inhibitors: a combined 3D-QSAR and molecular docking study.
    Wang FF; Yang W; Shi YH; Le GW
    J Biomol Struct Dyn; 2016 Dec; 34(12):2619-2631. PubMed ID: 26618241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling and molecular dynamics simulation studies on the interactions of hydroxylated polychlorinated biphenyls with estrogen receptor-β.
    Li X; Ye L; Wang X; Shi W; Qian X; Zhu Y; Yu H
    Arch Environ Contam Toxicol; 2013 Oct; 65(3):357-67. PubMed ID: 23712771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotoxicity of polychlorinated biphenyls: present status and future considerations.
    Tryphonas H
    Exp Clin Immunogenet; 1994; 11(2-3):149-62. PubMed ID: 7826664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Environmental Risk Characteristics of PCB Transformation Products in the Environmental Medium.
    Li M; He W; Yang H; Sun S; Li Y
    Toxics; 2021 Sep; 9(9):. PubMed ID: 34564364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CYP2E1-activated mutagenicity of dioxin-like PCBs 105 and 118-Experimental data consistent with molecular docking results.
    Hu K; Yu H; Li Z; Jin G; Jia H; Song M; Liu Y
    Toxicology; 2020 May; 437():152438. PubMed ID: 32199159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the binding free energy and PCBs' migration, persistence, toxicity and bioaccumulation using a combination of the molecular docking method and 3D-QSAR.
    Zhao XH; Wang XL; Li Y
    Chem Cent J; 2018 Feb; 12(1):20. PubMed ID: 29476294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico predictive studies of mAHR congener binding using homology modelling and molecular docking.
    Panda R; Cleave AS; Suresh PK
    Toxicol Ind Health; 2014 Sep; 30(8):765-76. PubMed ID: 23081860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.